Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNausea and diarrhoea are the most commonly reported side effects of Mounjaro (tirzepatide), and yes, they can genuinely disrupt your first few weeks. Most people find the sickness settles as the body adjusts; diarrhoea tends to be milder and shorter-lived than nausea for most. These medicines are prescription-only and started under clinical supervision — the full side-effect picture is broader than the gut symptoms, but the stomach effects are what patients ask about most. A prescriber assesses your medical history before treatment begins, and that assessment is where questions like these belong.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The tracking notification pings, DPD delivers a plain, unbranded box, and inside is your first Mounjaro KwikPen. For many people the first injection passes without incident. For others, within a day or two, a wave of nausea arrives, sometimes accompanied by looser stools or an urgency to the bathroom they weren't quite expecting.
This isn't a sign something has gone wrong. Tirzepatide activates receptors in the gut that slow gastric emptying and signal fullness to the brain. That slowing is exactly the mechanism that reduces appetite, but it's also why your stomach may feel unsettled, particularly while your body is calibrating to a dose it hasn't encountered before. The NHS patient information page for tirzepatide confirms nausea, diarrhoea, vomiting and constipation among the most commonly reported effects.
If you want to understand more about why Mounjaro sickness happens and what drives it, the mechanism becomes a lot clearer when you look at how tirzepatide interacts with the gut. That's why the titration schedule exists. The starting dose is about settling your system, not therapeutic weight loss yet, so the prescriber moves you up gradually rather than all at once. Eating smaller portions, avoiding high-fat or very rich food, and staying hydrated all have practical evidence behind them for reducing GI symptoms. So does eating slowly and not lying down for an hour after a meal.
Most people find things meaningfully better by week three or four at a given dose. That isn't universal, but it's the pattern our clinical team sees most often.
Both, potentially. The honest answer is that GI symptoms can resurface whenever the dose increases, even in someone who had no trouble at lower levels. The gut is adjusting to a new signal strength each time. For most people, the nausea of 5mg is less disruptive than 2.5mg was, because some tolerance has built up, but that's not guaranteed.
Diarrhoea on Mounjaro is generally reported less often than nausea. When it does occur, it's usually short-lived, appearing in the first day or two after an injection and resolving without treatment. Staying hydrated matters: repeated episodes of diarrhoea or vomiting can lead to dehydration, which in turn can stress the kidneys. That's not a reason to stop without speaking to your prescriber, it's a reason to keep fluid intake up and flag anything that isn't resolving.
A few practical approaches people find helpful: ginger tea, plain crackers, cold foods (which tend to have a less strong smell), and avoiding eating right before the injection. Our page on sickness from Mounjaro goes into these approaches in more detail, alongside the kind of practical suggestions that come up in conversations about managing these symptoms. Your prescriber and the Patient Information Leaflet are the right source for personal guidance.
Constipation is also possible, sometimes alternating with looser stools, because slowed gastric emptying affects the whole digestive transit. Fibre, hydration and keeping active help most people here too.
Most GI symptoms from Mounjaro are unpleasant but not dangerous. Some, though, need prompt medical assessment.
Acute pancreatitis is a known, infrequent but serious risk with GLP-1 receptor agonists including tirzepatide. In January 2026, the MHRA issued a Drug Safety Update specifically highlighting pancreatitis across this class of medicine. The symptom to act on is severe stomach pain that persists and radiates toward the back, particularly if it comes with vomiting that doesn't settle. Don't wait this one out. Call 111, go to urgent care, or call 999 if the pain is severe and sudden.
Also seek prompt help for: signs of a serious allergic reaction (swelling of the face, throat or tongue, difficulty breathing); gallbladder symptoms (sharp pain in the upper right abdomen, especially after eating); or if you cannot keep any fluids down for more than 24 hours, since dehydration can become a clinical problem faster than people expect.
You can report any suspected side effect (whether it's significant or just something that felt unusual) through the MHRA Yellow Card scheme. This matters: it's how the safety picture of newer medicines gets built up over time, and Mounjaro still carries a Black Triangle (▼) flag indicating additional monitoring is in place.
If you're on treatment with nume and something isn't feeling right, our support team is available seven days a week, you won't be left waiting for a Monday morning.
Some people are more prone to GI side effects than others, and a thorough consultation is the place to surface that. Someone with a history of gastroparesis, inflammatory bowel disease or certain other GI conditions may not be a suitable candidate; someone who has had severe nausea on another GLP-1 medicine will have that factored in. This is exactly why clinical review happens before a prescription is written, not as a formality.
Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above where a weight-related condition is present, alongside a reduced-calorie diet and increased activity. Lower BMI thresholds may apply for some ethnic backgrounds under UK clinical guidance. But eligibility on paper doesn't mean the medicine is right for every individual who fits the criteria, that judgement belongs to the prescriber, who reviews the whole picture.
If you're considering treatment and wondering whether your stomach will tolerate it, that's a conversation worth having before you start. Our prescribers discuss suitability and side effects as part of the consultation, check your eligibility and begin that conversation here. There's no obligation, and the consultation is free.
For a broader overview of how Mounjaro works and what treatment involves, or to read about the process of accessing it through a regulated UK pharmacy, those pages cover the wider picture.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.